SAN JOSE, CA, Jul 25, 2012 (MARKETWIRE via COMTEX) — Intelleflex, a leading provider of on-demand data visibility solutions for supply chains and asset tracking, supports the findings of a study published by the Parenteral Drug Association (PDA) that RFID technology is both safe and suitable for use in the presence of biologics. The study, “Effects of Radio Frequency Identification-related Radiation on In Vitro Biologics,” was conducted by researchers at The University of South Florida, Blood Center of Wisconsin, Abbott, Georgia Institute of Technology and the Madison RFID Lab at the University of Wisconsin and was published in the July-August edition of the PDA Journal of Pharmaceutical Science and Technology.
See on www.marketwatch.com
Latest posts by Jake Cmarada (see all)
- MOBOTIX News 09/2012 – News 2012 – News – Company – Home - November 6, 2012
- Moscow Metro Tests Anti-Terror CCTV System | Crime | RIA Novosti - October 19, 2012
- SMARTPROC.com - October 11, 2012